Evolutionary trend of invasive pneumococcal disease according to serotypes

Maria Jose Galvez Medina (Madrid, Spain), Maria Jose Galvez Medina, Angela Ramos Pinedo, Jose Francisco Valverde Canovas, Elia Perez, Javier Solano, Mercedes Izquierdo, Nurua Echave, Marta Inmaculada Hernandez

Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Session: Community-acquired pneumonia: from prevention to treatment
Session type: Poster Discussion
Number: 613
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Maria Jose Galvez Medina (Madrid, Spain), Maria Jose Galvez Medina, Angela Ramos Pinedo, Jose Francisco Valverde Canovas, Elia Perez, Javier Solano, Mercedes Izquierdo, Nurua Echave, Marta Inmaculada Hernandez. Evolutionary trend of invasive pneumococcal disease according to serotypes. Eur Respir J 2016; 48: Suppl. 60, 613

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Invasive pneumococcal disease (IPN) and pneumococcal vaccination in our setting
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Clinical features of adults with seven-valent- conjugated-vaccine- serotype pneumococcal pneumonia
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013


Impact of the vaccination campaign on pneumococcal pneumonia after the great East Japan earthquake
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Clinical presentations and serotypes causing invasive pneumococcal disease in adults vaccinated with the 23-valent polysaccharide pneumococcal vaccine (PPV23) in Spain. The ODIN study (2010-2013)
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014


Impact of introducing the 10-valent pneumococcal conjugate vaccine on childhood hospitalizations for bacterial pneumonia in Brazil
Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma
Year: 2013

The remaining challenges of pneumococcal disease in adults
Source: Eur Respir Rev 2012; 21: 57-65
Year: 2012



Impact of bacterial coinfection on clinical outcomes in pneumococcal pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Risk of hospitalization due to pneumococcal pneumonia in adults in Spain. The CORIENNE study
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Immunity to pneumococcal disease
Source: Annual Congress 2013 –New understanding of pneumococcal vaccination
Year: 2013


Differences of clinical manifestation between influenza subtypes
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016


Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes
Source: Eur Respir J 2014; 43: 545-553
Year: 2013




Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017


Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017

The risk factors of clinical practice for bacteremia in community- acquired pneumococcal pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Clinical features of influenza virus infection of 2013/2014 season
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015


Influenza vaccination is associated with reduced severity of community-acquired pneumonia
Source: Eur Respir J 2011; 37: 147-153
Year: 2011



Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia
Source: Eur Respir J 2010; 36: 1073-1079
Year: 2010



Pneumococcal carriage and serotypes distribution in patients with acute otitis media in Switzerland, 2004-2014
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016


Bacteremic vs. non-bacteremic pneumococcal pneumonia in immunocompetent patients: Predictive and prognostic factors
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016

How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia
Source: Eur Respir J 2011; 37: 1151-1157
Year: 2011